Blog

Jul 13, 2022

Verve starts first human test of gene editing treatment for heart disease

Posted by in categories: bioengineering, biotech/medical

A patient in New Zealand became the first person to receive the biotech’s medicine, which uses base editing to turn off a specific gene in the liver and thereby lower cholesterol.

0 comments

Comments are closed.

Tag cloud

aging AI Alzheimer's anti-aging Artificial Intelligence bioquantine bioquark biotech biotechnology bitcoin blockchain brain death cancer cryptocurrency culture Death existential risks extinction future futurism Google health healthspan humanity ideaxme immortality Interstellar Travel ira pastor Life extension lifespan longevity NASA Neuroscience politics reanima regenerage regeneration research risks singularity space sustainability technology transhumanism wellness

Categories